JP2011522777A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522777A5
JP2011522777A5 JP2010548312A JP2010548312A JP2011522777A5 JP 2011522777 A5 JP2011522777 A5 JP 2011522777A5 JP 2010548312 A JP2010548312 A JP 2010548312A JP 2010548312 A JP2010548312 A JP 2010548312A JP 2011522777 A5 JP2011522777 A5 JP 2011522777A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
group
cell
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010548312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522777A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/002587 external-priority patent/WO2009150822A1/en
Publication of JP2011522777A publication Critical patent/JP2011522777A/ja
Publication of JP2011522777A5 publication Critical patent/JP2011522777A5/ja
Ceased legal-status Critical Current

Links

JP2010548312A 2008-06-10 2009-06-09 Mybl2エピトープペプチドおよびそれを含むワクチン Ceased JP2011522777A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6029308P 2008-06-10 2008-06-10
US61/060,293 2008-06-10
PCT/JP2009/002587 WO2009150822A1 (en) 2008-06-10 2009-06-09 Mybl2 epitope peptides and vaccines containing the same

Publications (2)

Publication Number Publication Date
JP2011522777A JP2011522777A (ja) 2011-08-04
JP2011522777A5 true JP2011522777A5 (enExample) 2012-09-06

Family

ID=41416535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010548312A Ceased JP2011522777A (ja) 2008-06-10 2009-06-09 Mybl2エピトープペプチドおよびそれを含むワクチン

Country Status (13)

Country Link
US (1) US20110189213A1 (enExample)
EP (1) EP2297180A4 (enExample)
JP (1) JP2011522777A (enExample)
KR (1) KR20110016952A (enExample)
CN (1) CN102119170A (enExample)
AU (1) AU2009258775B2 (enExample)
BR (1) BRPI0913436A2 (enExample)
CA (1) CA2727482A1 (enExample)
IL (1) IL209870A0 (enExample)
MX (1) MX2010013688A (enExample)
RU (1) RU2496787C2 (enExample)
TW (1) TW201000119A (enExample)
WO (1) WO2009150822A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201200525A (en) * 2009-12-04 2012-01-01 Oncotherapy Science Inc MYBL2 peptides and vaccines containing the same
KR20140138900A (ko) 2012-03-09 2014-12-04 온코세라피 사이언스 가부시키가이샤 펩티드를 포함한 의약 조성물
CN104004062B (zh) * 2014-06-25 2016-03-16 刘元超 关于per2蛋白激动剂多肽及其应用
CN104045693B (zh) * 2014-06-25 2016-12-07 杨高林 一种关于per2蛋白激动剂多肽及其应用
CN104017054B (zh) * 2014-06-25 2016-12-07 南安市威速电子科技有限公司 Per2蛋白激动剂多肽及其应用
WO2017194170A1 (en) * 2016-05-13 2017-11-16 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
EP3463400A4 (en) * 2016-05-23 2020-07-29 The Council of the Queensland Institute of Medical Research CMV EPITOPES
WO2018045510A1 (zh) * 2016-09-07 2018-03-15 武汉华大吉诺因生物科技有限公司 多肽及其应用
CN109136376B (zh) * 2018-05-21 2021-09-21 中国医科大学附属第四医院 一种膀胱癌相关环状RNA的应用和siRNA及其用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253486A (ja) * 1988-08-19 1990-02-22 Rikagaku Kenkyusho ヒトmyb関連遺伝子
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
EP2189470A1 (en) * 2001-12-10 2010-05-26 Green Peptide Co., Ltd. Tumor antigens
WO2004018667A1 (ja) * 2002-08-26 2004-03-04 Kirin Beer Kabushiki Kaisha ペプチド及びこれを含む医薬
EP1548032B9 (en) * 2002-09-12 2009-10-28 Oncotherapy Science, Inc. Kdr peptides and vaccines comprising the same
AU2003260965A1 (en) * 2002-09-30 2004-04-23 Japan As Represented By The President Of The University Of Tokyo Method for diagnosing testicular seminomas
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
US20050260639A1 (en) * 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
US7871769B2 (en) * 2004-04-09 2011-01-18 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
JP4547197B2 (ja) * 2004-06-30 2010-09-22 公正 安元 癌特異的腫瘍抗原
CA2583375C (en) * 2004-09-02 2013-01-15 Yale University Regulation of oncogenes by micrornas
ES2319286T3 (es) * 2004-10-02 2009-05-06 Immatics Biotechnologies Gmbh Epitopos inmunogenos de linfocitos t colaboradores de antigenos de tumor humanos y utilizacion de dichos epitopos en metodos inmunoterapeuticos.
AU2005304824B2 (en) * 2004-11-05 2011-12-22 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
ES2384107T3 (es) * 2004-11-05 2012-06-29 Genomic Health, Inc. Indicadores moleculares de pronóstico de cáncer de mama y predicción de la respuesta al tratamiento
EP2011885B1 (en) * 2005-02-10 2015-04-22 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
CA2680945C (en) * 2005-06-17 2014-03-18 Imclone Systems Incorporated Anti-pdgfralpha antibodies
WO2007013665A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
CN101273144B (zh) * 2005-07-27 2011-12-28 肿瘤疗法科学股份有限公司 诊断食道癌的方法
WO2007066423A1 (ja) * 2005-12-08 2007-06-14 Dainippon Sumitomo Pharma Co., Ltd. Amacr由来の腫瘍抗原ペプチド
JP2009091249A (ja) * 2006-01-23 2009-04-30 Univ Kurume C型肝炎ウイルス2a由来HLA−A2拘束性抗原ペプチド
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer

Similar Documents

Publication Publication Date Title
JP2011524737A5 (enExample)
JP2011522777A5 (enExample)
JP2012500001A5 (enExample)
JP2012517799A5 (enExample)
JP2010523471A5 (enExample)
RU2009141595A (ru) Пептиды тем8 и содержащие их вакцины
JP2010506826A5 (enExample)
RU2009118432A (ru) Пептидные вакцины против рака с экспрессией полипептидов mphosph1 или depdc1
JP2010519176A5 (enExample)
JP2012510431A5 (enExample)
RU2011101709A (ru) Cdca1 эпитоп-пептиды и содержащие их вакцины
RU2010154081A (ru) Эпитопные пептиды iqgap3 вакцины, содержащие их
JP2013511958A5 (enExample)
RU2010154101A (ru) Пептиды эпитопов mybl2 и содержащие их вакцины
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
JP2011523937A5 (enExample)
JP2013523084A5 (enExample)
JP2011529683A5 (enExample)
JP2012520659A5 (enExample)
RU2012136464A (ru) Модифицированные пептиды melk и содержащие их вакцины
JP2013517764A5 (enExample)
JP2010535504A5 (enExample)
RU2014109137A (ru) Пептиды mphosph1 и вакцины, включающие их
JP2012527867A5 (enExample)
RU2015113436A (ru) Пептиды ube2t и содержащие их вакцины